|
SAPS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.148800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.918600E-01 |
| Normal-vs-Stage2 |
8.964000E-01 |
| Normal-vs-Stage3 |
3.755400E-01 |
| Normal-vs-Stage4 |
1.978190E-02 |
| Stage1-vs-Stage2 |
9.443800E-01 |
| Stage1-vs-Stage3 |
3.295800E-01 |
| Stage1-vs-Stage4 |
1.446170E-01 |
| Stage2-vs-Stage3 |
4.687000E-01 |
| Stage2-vs-Stage4 |
1.948830E-01 |
| Stage3-vs-Stage4 |
4.421800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.751600E-01 |
| Normal-vs-AfricanAmerican |
6.639400E-01 |
| Normal-vs-Asian |
6.881800E-01 |
| Caucasian-vs-AfricanAmerican |
6.795800E-01 |
| Caucasian-vs-Asian |
6.351000E-01 |
| AfricanAmerican-vs-Asian |
5.230000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.245800E-01 |
| Normal-vs-Female |
2.064000E-01 |
| Male-vs-Female |
1.911640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.939200E-01 |
| Normal-vs-Extreme_Weight |
7.501000E-01 |
| Normal-vs-Obese |
5.132000E-01 |
| Normal-vs-Extreme_Obese |
5.109000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.231400E-01 |
| Normal_Weight-vs-Obese |
3.196600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.147600E-01 |
| Extreme_Weight-vs-Obese |
4.033800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.215000E-01 |
| Obese-vs-Extreme_Obese |
4.689600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.085000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.756200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.879600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.160600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.851600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.402630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.520400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.123100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.329600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.294200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.841590E-02 |
| Normal-VS-Type2 PRCC |
2.988200E-04 |
| Normal-VS-KIRP CIMP |
2.524800E-01 |
| Normal-VS-Unclassified PRCC |
6.878000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.54120005435976E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.021410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.087000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.191600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.191960E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.373000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.134800E-01 |
| Normal-vs-N1 |
5.649000E-01 |
| Normal-vs-N2 |
6.218200E-03 |
| N0-vs-N1 |
7.625000E-01 |
| N0-vs-N2 |
1.652580E-01 |
| N1-vs-N2 |
1.720960E-01 |
|
|
